RISKS OF IMMUNODEFICIENCY, AIDS, AND DEATH RELATED TO PURITY OF FACTOR-VIII CONCENTRATE

被引:45
作者
GOEDERT, JJ
COHEN, AR
KESSLER, CM
EICHINGER, S
SEREMETIS, SV
RABKIN, CS
YELLIN, FJ
ROSENBERG, PS
ALEDORT, LM
机构
[1] NCI,VIRAL EPIDEMIOL BRANCH,AIDS & CANC SECT,ROCKVILLE,MD
[2] CHILDRENS HOSP PHILADELPHIA,PHILADELPHIA,PA 19104
[3] GEORGE WASHINGTON UNIV HOSP,WASHINGTON,DC
[4] UNIV VIENNA,VIENNA,AUSTRIA
[5] MT SINAI MED CTR,NEW YORK,NY 10029
[6] COMP SCI CORP,PROFESS SERV GRP,ROCKVILLE,MD
[7] NCI,EPIDEMIOL METHODS SECT,ROCKVILLE,MD
关键词
D O I
10.1016/S0140-6736(94)92345-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In HIV-infected subjects with haemophilia, CD4 counts seem to fall more slowly in those on high-purity factor VIII (FVIII) than on intermediate-purity product. We evaluated whether risks for AIDS or death were associated with either product among 411 HIV-infected individuals. The relative hazard of AIDS was slightly elevated for both current (1.34 per month) and cumulative (1.01 per month) use of high-purity products (neither significant). The corresponding hazards for death were 1.49 and 1.03 (neither significant). Thus we found no evidence that high-purity FVIII concentrates retard the development of AIDS.
引用
收藏
页码:791 / 792
页数:2
相关论文
共 9 条
  • [1] CD4+ LYMPHOCYTES ARE AN INCOMPLETE SURROGATE MARKER FOR CLINICAL PROGRESSION IN PERSONS WITH ASYMPTOMATIC HIV-INFECTION TAKING ZIDOVUDINE
    CHOI, SS
    LAGAKOS, SW
    SCHOOLEY, RT
    VOLBERDING, PA
    [J]. ANNALS OF INTERNAL MEDICINE, 1993, 118 (09) : 674 - 680
  • [2] DEBIASI R, 1991, BLOOD, V78, P1919
  • [3] A PROSPECTIVE-STUDY OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 INFECTION AND THE DEVELOPMENT OF AIDS IN SUBJECTS WITH HEMOPHILIA
    GOEDERT, JJ
    KESSLER, CM
    ALEDORT, LM
    BIGGAR, RJ
    ANDES, WA
    WHITE, GC
    DRUMMOND, JE
    VAIDYA, K
    MANN, DL
    EYSTER, ME
    RAGNI, MV
    LEDERMAN, MM
    COHEN, AR
    BRAY, GL
    ROSENBERG, PS
    FRIEDMAN, RM
    HILGARTNER, MW
    BLATTNER, WA
    KRONER, B
    GAIL, MH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (17) : 1141 - 1148
  • [4] GOLDSMITH JM, 1991, THROMB HAEMOSTASIS, V66, P415
  • [5] PURITY OF FACTOR-VIII CONCENTRATES AND SERIAL CD4 COUNTS
    HILGARTNER, MW
    BUCKLEY, JD
    OPERSKALSKI, EA
    PIKE, MC
    MOSLEY, JW
    [J]. LANCET, 1993, 341 (8857) : 1373 - 1374
  • [6] PRESTON DL, 1990, EPICURE RISK REGRESS
  • [7] 3-YEAR RANDOMIZED STUDY OF HIGH-PURITY OR INTERMEDIATE-PURITY FACTOR-VIII CONCENTRATES IN SYMPTOM-FREE HIV-SEROPOSITIVE HEMOPHILIACS - EFFECTS ON IMMUNE STATUS
    SEREMETIS, SV
    ALEDORT, LM
    BERGMAN, GE
    BONA, R
    BRAY, G
    BRETTLER, D
    EYSTER, ME
    KESSLER, C
    LAU, TS
    LUSHER, J
    RICKLES, F
    [J]. LANCET, 1993, 342 (8873) : 700 - 703
  • [8] TREND AND HOMOGENEITY ANALYSES OF PROPORTIONS AND LIFE TABLE DATA
    THOMAS, DG
    BRESLOW, N
    GART, JJ
    [J]. COMPUTERS AND BIOMEDICAL RESEARCH, 1977, 10 (04): : 373 - 381
  • [9] 1994, LANCET, V343, P871